Description
Peptide B is a fibrinogen-like peptide that acts as a vascular vasoconstrictor. In vivo, it exhibits hemostatic activity, decreasing bleeding time. Peptide B also accelerates effects associated with superprecipitation of myosin B.
Peptide B is a fibrinogen-like peptide that acts as a vascular vasoconstrictor. In vivo, it exhibits hemostatic activity, decreasing bleeding time. Peptide B also accelerates effects associated with superprecipitation of myosin B.
| Purity | ≥95% |
|---|---|
| Formula | C98H145N25O26S2 |
| Formula Wt. | 2153.49 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Nichols WW, Mehta J, Wargovich T, et al. Fibrin(ogen)-derived peptide B beta 30-43 increases coronary blood flow in the anesthetized dog. Thromb Res. 1985 Jul 15;39(2):223-9. PMID: 3895564.
Osbahr AJ, Custodio R. Action of peptide-B from bovine fibrinogen on ATPase activity and superprecipitation of myosin B. Am J Physiol. 1975 Feb;228(2):488-95. PMID: 123418.
Osbahr AJ. The hemostatic effect of bovine peptide-B from fibrinogen. Thromb Diath Haemorrh. 1974 Sep 30;32(1):149-56. PMID: 4454037.
Benzoquinone ansamycin; topoisomerase VI-B, HSP...
PKC and S6 kinase substrate.
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
Synthetic steroid hormone used in HRT; SERM, PR...
MEK1/2 inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
β1-adrenergic antagonist.
Podophyllotoxin derivative; topoisomerase II in...
HIV and AIDS
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Alkaline phosphatase substrate used to quantify...
NSAID; COX-1/2 inhibitor.
Endogenous peptide hormone, involved in intesti...
Fluoroquinolone; topoisomerase IV and bacterial...
α2-adrenergic and imidazoline-1 antagonist, AT...
PPARγ agonist, AT1 inhibitor.
Peptide, neutral ionophore.
PAI-1 inhibitor.
Peptide; NMDA partial agonist.